Show simple item record

FieldValueLanguage
dc.contributor.authorLipworth, W
dc.contributor.authorKerridge, I
dc.contributor.authorBrett, J
dc.contributor.authorDay, R
dc.date.accessioned2014-06-23
dc.date.available2014-06-23
dc.date.issued2011-01-01
dc.identifier.citationLipworth W, Kerridge I, Brett J, Day R. How clinical and research failures lead to suboptimal prescribing: the example of chronic gout. BMJ. 2011. 343:d7459.en
dc.identifier.urihttp://hdl.handle.net/2123/10795
dc.description.abstractDespite the existence of several effective drugs for chronic tophaceous gout, management is often neither rational nor effective. Wendy Lipworth and colleagues examine the possible reasons An evidence based or “rational” approach to prescribing is thought to maximise the benefit and minimise the harm from prescription drugs. Unfortunately, prescribing often does not meet this ideal despite clinicians’ best intentions. We use treatment of chronic tophaceous gout to show how apparently irrational prescribing arises from several interacting “failures” in both clinical practice and drug development.en
dc.language.isoen_AUen
dc.publisherBMJen
dc.rightsOther
dc.titleHow clinical and research failures lead to suboptimal prescribing: the example of chronic gouten
dc.typeArticleen
dc.identifier.doi10.1136/bmj.d7459
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney Health Ethicsen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.